1
ꢉꢉꢀꢀꢀꢀꢁꢀS. Hashemi-Uderji et al.: FSM-16-SO H nanoparticles as a novel heterogeneous catalyst
3
1
1
1
692 (C=O), 1657 (C=O), 1620 (C=C), 1288 (C-O), 1035 (C-N). H NMR 1693 (C=O), 1659 (C=O), 1611 (C=C), 1290 (C-O), 1039 (C-N). H NMR
(
500 MHz, CDCl ): δ (ppm)ꢁ=ꢁ1.02 (s, 3H), 1.13 (s, 3H), 1.20 (t, 3H, (500 MHz, CDCl ): δ (ppm)ꢁ=ꢁ0.87 (s, 3H), 1.01 (s, 3H), 1.06 (t, 3H,
3
3
Jꢁ=ꢁ7.0 Hz), 2.20 (d, 1H, Jꢁ=ꢁ16.0 Hz), 2.26 (d, 1H, Jꢁ=ꢁ16.0 Hz), 2.46 (s, 2H), Jꢁ=ꢁ7.05 Hz), 2.05 (d, 1H, Jꢁ=ꢁ16.05 Hz), 2.24 (d, 1H, Jꢁ=ꢁ16.05 Hz), 2.49
.06–4.09 (m, 2H), 4.70 (s, 1H), 6.28 (s, 2H, NH ), 7.10 (t, 1H, Jꢁ=ꢁ7.6 Hz), (s, 2H), 3.93 (q, 2H, Jꢁ=ꢁ7.05 Hz), 4.49 (s, 1H), 7.00 (t, 2H, Jꢁ=ꢁ3.05 Hz),
4
2
13
13
7
.23 (d, 1H, Jꢁ=ꢁ7.7 Hz), 7.26 (d, 1H, Jꢁ=ꢁ7.8 Hz), 7.42 (s, 1H). C NMR 7.13–7.16 (m, 2H), 7.57 (s, 2H, NH ). C NMR (125.72 MHz, CDCl ): δ
2
3
(
125.72 MHz, CDCl ): δ (ppm)ꢁ=ꢁ14.6, 27.9, 29.5, 32.7, 34.2, 41.1, 51.1, 60.2, (ppm)ꢁ=ꢁ14.6, 26.9, 29.0, 32.3, 33.1, 40.0, 50.39, 59.2, 78.1, 114.8, 115.8,
3
8
0.5, 116.5, 122.3, 127.5, 129.6, 129.7, 131.8, 148.6, 158.7, 162.1, 169.3, 196.7. 129.9, 143.0, 159.6, 160.9, 162.5, 168.3, 196.2.
Ethyl
2-amino-1,4,5,6,7,8-hexahydro-7,7-dimethyl-4-(3- Ethyl
2-amino-1,4,5,6,7,8-hexahydro-4-(3,5-dimethoxyphenyl)-
nitrophenyl)-5-oxoquinoline-3-carboxylate (5f):ꢂLight yellow solid, 7,7-dimethyl-5-oxoquinoline-3-carboxylate (5k):ꢂLight yellow solid,
−1
−1
mp 183°C–184°C. IR (KBr) υ (cm ): 3440 (NH ), 3300 (NH ), 3208 mp 222°C–226°C. IR (KBr) υ (cm ): 3436 (NH ), 3304 (NH ), 3197
max
2
2
max
2
2
1
1
(
NH), 1692 (C=O), 1671 (C=O), 1622 (C=C), 1251 (C-O), 1038 (C-N). H (NH), 1690 (C=O), 1663 (C=O), 1592 (C=C), 1285 (C-O), 1038 (C-N). H
NMR (500 MHz, CDCl ): δ (ppm)ꢁ=ꢁ1.00 (s, 3H), 1.13 (s, 3H), 1.17 (t, 3H, NMR (500 MHz, CDCl ): δ (ppm)ꢁ=ꢁ1.03 (s, 3H), 1.10 (s, 3H), 1.22 (t, 3H,
3
3
Jꢁ=ꢁ7.1 Hz), 2.17 (d, 1H, Jꢁ=ꢁ16.0 Hz), 2.27 (d, 1H, Jꢁ=ꢁ16.0 Hz), 2.50 (s, 2H), J =7.2 Hz), 2.22 (d, 1H, Jꢁ=ꢁ16.2 Hz), 2.26 (d, 1H, Jꢁ=ꢁ16.2 Hz), 2.40 (s,
.03–4.07 (m, 2H), 4.81 (s, 1H), 6.40 (s, 2H, NH ), 7.40 (t, 1H, Jꢀ=ꢀ7.9 Hz), 2H), 3.78 (s, 6H), 4.06–4.13 (m, 2H), 4.70 (s, 1H), 6.23 (s, 2H, NH ) 6.27
4
2
2
1
3
13
7
.67 (d, 1H, Jꢀ=ꢀ7.9 Hz), 8.00 (d, 1H, Jꢁ=ꢁ7.9 Hz), 8.13 (s, 1H). C NMR (t, 1H, Jꢁ=ꢁ1.6 Hz), 6.48 (d, 2H, Jꢁ=ꢁ2.0 Hz). C NMR (125.72 MHz, CDCl ):
3
(
1
125.72 MHz, CDCl ): δꢁ=ꢁ14.6, 27.7, 29.4, 32.6, 34.6, 41.0, 51.0, 60.3, 79.9, δ (ppm)ꢁ=ꢁ14.0, 26.9, 29.1, 32.0, 34.2, 41.0, 51.0, 55.3, 60.1, 80.1, 98.0,
16.0, 121.7, 123.6, 128.9, 135.3, 148.5, 148.6, 158.8, 162.5, 169.0, 196.7.
3
117.0, 148.0, 158.1, 160.0, 161.0, 169.2, 196.0. Anal. Calcd. for C H N O :
22 28 2 5
C, 65.98; H, 7.05; N, 7.00. Found: C, 65.88; H, 7.03; N, 7.20.
Ethyl
hexahydroquinoline-3-carboxylate (5g):ꢂLight yellow solid, mp
72°C–175°C [179°C–181°C Lit. (Abdollahi-Alibeik and Rezaeipoor-
2-amino-7,7-dimethyl-5-oxo-4-(pyridin-3-yl)-1,4,5,6,7,8-
Acknowledgment: We are thankful to the Yazd University
Research Council for partial support of this work.
1
−1
Anari, 2016)]. IR (KBr) υmax (cm ): 3440 (NH ), 3335 (NH ), 3200 (NH),
2
2
1
1
690 (C=O), 1663 (C=O), 1622 (C=C), 1279 (C-O), 1040 (C-N). H NMR
(
400MHz, (CDCl ): δ (ppm)ꢁ=ꢁ0.99 (s, 3H), 1.12 (s, 3H), 1.16 (t, 3H,
3
Jꢁ=ꢁ7.0 Hz), 2.17 (d, 1H, Jꢁ=ꢁ16.2 Hz), 2.25 (d, 1H, Jꢀ=ꢀ16.2 Hz), 2.46 (s, 2H),
4
.03–4.04 (m, 2H), 4.71 (s, 1H), 6.29 (s, 2H, NH ), 7.14–7.17 (m, 1H), References
2
13
7
.58–7.61 (m, 1H), 8.36–8.37 (m, 1H), 8.53 (s, 1H). C NMR (100 MHz,
(CDCl ): δ (ppm)ꢁ=ꢁ14, 27, 29, 31, 40, 50, 51, 60, 79, 116, 123, 136, 141, 147,
−
3
Abdollahi-Alibeik, M.; Hoseinikhah, S. S. ClO4 /Zr-MCM-41
1
1
50, 159, 162, 169, 196. Anal. Calcd. for C H N O : C, 66.84; H, 6.79; N,
2.31. Found: C, 66.73; H, 6.61; N, 12.37.
19
23
3
3
nanoparticles prepared at mild conditions: a novel solid acid
catalyst for the synthesis of polyhydroquinolines. J. Iran Chem.
Soc. 2ꢉ16, 13, 1339–1347.
Ethyl-2-amino-4-(2-chlorophenyl)-7,7-dimethyl-5-oxo-
,4,5,6,7,8-hexahydroquinoline-3-carboxylate (5h):ꢂWhite solid,
mp 182°C–183°C [183°C–185°C Lit. (Abdollahi-Alibeik and Rezaeipoor-
Abdollahi-Alibeik, M.; Pouriayevali, M. 12-Tungstophosphoric acid
supported on nano sized MCM-41 as an efficient and reusable
solid acid catalyst for the three-component imino Diels–Alder
reaction. React. Kinet. Mech. Cat. 2ꢉ11, 104, 235–248.
Abdollahi-Alibeik, M.; Rezaeipoor-Anari, A. BF3/MCM-41 as nano
structured solid acid catalyst for the synthesis of 3-iminoaryl-
imidazo[1,2-a]pyridines. Cat. Sci. Tech. 2ꢉ14, 4, 1151–1159.
Abdollahi-Alibeik, M.; Rezaeipoor-Anari, A. MCM-41 functionalized
with B-F bond: preparation, characterization and catalytic appli-
cation in the synthesis of polyhydroquinolines. Lett. Org. Chem.
2ꢉ15, 12, 651–658.
1
−1
Anari, 2016)]. IR (KBr) υmax (cm ): 3420 (NH ), 3309 (NH ), 3215 (NH),
2
2
1
1
693 (C=O), 1655 (C=O), 1613 (C=C), 1294 (C-O), 1038 (C-N). H NMR
400 MHz, DMSO-d6): δ (ppm)ꢁ=ꢁ0.93 (s, 3H), 1.02 (t, 3H, Jꢁ=ꢁ7.2 Hz),
.03 (s, 3H), 2.02 (d, 1H, Jꢁ=ꢁ16.1 Hz), 2.25 (d, 1H, Jꢁ=ꢁ16.1 Hz), 2.39–2.59
m, 2H), 3.91 (q, 2H, Jꢁ=ꢁ7.0 Hz), 4.83 (s, 1H), 7.21–7.25 (m, 4H), 7.65
(
1
(
(
1
3
s, 2H, NH ). C NMR (100 MHz, DMSO-d6): δ (ppm)ꢁ=ꢁ14.1, 26.4, 28.6,
2
3
1.7, 32.2, 49.9, 55.7, 76.3, 113.9, 126.3, 127.3, 129.2, 131.8, 132.6, 142.7,
1
6
59.2, 162.2, 168.1, 195.6. Anal. Calcd. for C H ClN O : C, 64.08; H,
2
0
23
2
3
.18; N, 7.47. Found: C, 63.96; H, 5.98; N, 7.53.
Abdollahi-Alibeik, M.; Rezaeipoor-Anari, A. Fe3O4@B-MCM-41: a
new magnetically recoverable nanostructured catalyst for the
synthesis of polyhydroquinolines. J. Magn. Magn. Mater. 2ꢉ16,
398, 205–214.
Ethyl 2-amino-1,4,5,6,7,8-hexahydro-4-(4-methoxyphenyl)-7,7-di-
methyl-5-oxoquinoline-3-carboxylate (5i):ꢂLight yellow solid, mp
1
28°C–130°C. [122°C–125°C Lit. (Kumar et al., 2008)]. IR (KBr) υ
Adharvana Chari, M.; Syamasundar, K. Silica gel/NaHSO catalyzed
max
4
−1
(
cm ): 3413 (NH ), 3304 (NH ), 3226 (NH), 1690 (C=O), 1668 (C=O),
one-pot synthesis of Hantzsch 1,4-dihydropyridines at ambient
2
2
1
1
621 (C=C), 1288 (C-O), 1036 (C-N). H NMR (500 MHz, CDCl ): δ
temperature. Catal. Commun. 2ꢉꢉ5, 6, 624–626.
3
(
ppm)ꢁ=ꢁ0.89 (s, 3H), 1.02 (s, 3H), 1.09 (t, 3H, Jꢁ=ꢁ7.0 Hz), 2.04 (d, 1H, Araki, H.; Fukuoka, A.; Sakamoto, Y.; Inagaki, S.; Sugimoto, N.; Fuku-
Jꢁ=ꢁ20.0 Hz), 2.24 (d, 1H, Jꢁ=ꢁ20.0 Hz), 2.46 (s, 2H), 3.66 (s, 3H), 3.90–3.97
shima, Y.; Ichikawa, M. Template synthesis and characterization
of gold nano-wires and particles in mesoporous channels of
FSM-16. J. Mol. Catal. A: Chem. 2ꢉꢉ3, 199, 95–102.
(
m, 2H), 4.44 (s, 1H), 6.75 (d, 2H, Jꢁ=ꢁ5.0 Hz), 7.02 (d, 2H, Jꢁ=ꢁ5.0 Hz), 7.49
1
3
(
s, 2H, NH ). C NMR (125.72 MHz, CDCl ): δ (ppm)ꢁ=ꢁ14.7, 26.9, 29.1,
2
3
3
2.3, 32.8, 40.5, 50.5, 55.3, 59.2, 78.5, 113.5, 116.2, 129.0, 138.9, 157.7, Boer, R.; Gekeler, V. Chemosensitizers in tumor therapy: new
159.5, 162.5, 168.5, 196.2.
compounds promise better efficacy. Drug Future 1995, 20,
99–510.
2-amino-4-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-7,7-di- Bretzel, R.; Bollen, C.; Maeser, E.; Federlin, K. Trombodipine
4
Ethyl
methyl-5-oxoquinoline-3-carboxylate (5j):ꢂLight yellow solid, mp
platelet aggregation inhibitor antithrombotic. Drug Future 1992,
17, 465.
−1
155°C–158°C. IR (KBr) υ (cm ): 3402 (NH ), 3289 (NH ), 3212 (NH),
max 2 2
Brought to you by | University of Sussex Library
Authenticated
Download Date | 8/14/18 9:06 PM